Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6641)
All Articles published online
|
Publishing Process of This Article
|
May 28, 2014 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Aguado C, García-Paredes B, Sotelo MJ, Sastre J, Díaz-Rubio E. Should capecitabine replace 5-fluorouracil in the first-line treatment of metastatic colorectal cancer? World J Gastroenterol 2014; 20(20): 6092-6101 [PMID: 24876731 DOI: 10.3748/wjg.v20.i20.6092] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i20/6092.htm |
| Number | Citing Articles |
| 1 |
Lucía Cortejoso, Xandra García-González, María I García, Pilar García-Alfonso, María Sanjurjo, Luis A López-Fernández. Cost–effectiveness of screening for DPYD polymorphisms to prevent neutropenia in cancer patients treated with fluoropyrimidines. Pharmacogenomics 2016; 17(9): 979 doi: 10.2217/pgs-2016-0006
|
| 2 |
Majed Alshamrani, Atika AlHarbi, Nora Alkhudair, Fouad AlNajjar, Mansoor Khan, Abdulaziz Ben Obaid, Amr Khardaly, Eshtyag Bajnaid, Hadeel Samarkandi, Aeshah AlAzmi, Salman Alabdali, Mohammed AlNahedh. Practical strategies to manage cancer patients during the COVID-19 pandemic: Saudi Oncology Pharmacy Assembly Experts recommendations. Journal of Oncology Pharmacy Practice 2020; 26(6): 1429 doi: 10.1177/1078155220935564
|
| 3 |
Maryam Naghsh-Nejad, Serena Yu, Philip Haywood. Provider responses to the expansion of public subsidies in healthcare: The case of oral chemotherapy treatment in Australia. Social Science & Medicine 2023; 330: 116041 doi: 10.1016/j.socscimed.2023.116041
|
| 4 |
VM Patil, S Chakraborty, TK Jithin, S Dessai, TP Sajith Babu, V Raghavan, M Geetha, TShiva Kumar, MS Biji, A Bhattacharjee, C Nair. Development and validation of a questionnaire to measure preferences and expectations of patients undergoing palliative chemotherapy: EXPECT questionnaire. Indian Journal of Cancer 2016; 53(2): 339 doi: 10.4103/0019-509X.197735
|
| 5 |
Chengyi Mao, Xiaoxi Zeng, Chao Zhang, Yushang Yang, Xin Xiao, Siyuan Luan, Yonggang Zhang, Yong Yuan. Mechanisms of Pharmaceutical Therapy and Drug Resistance in Esophageal Cancer. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.612451
|
| 6 |
Dong-hyun Lee, Sin Seong, Yunsik Won. Traditional Korean medicine as second-line treatment of metastatic colorectal cancer. Medicine: Case Reports and Study Protocols 2021; 2(2): e0042 doi: 10.1097/MD9.0000000000000042
|
| 7 |
Gary Mitchell, Sam Porter, Elizabeth Manias. From telling to sharing to silence: A longitudinal ethnography of professional‐patient communication about oral chemotherapy for colorectal cancer. Psycho-Oncology 2019; 28(2): 336 doi: 10.1002/pon.4945
|
| 8 |
Jingjing Sha, Yunpeng Bai, Huy Xuan Ngo, Tatsuo Okui, Takahiro Kanno. Overview of Evidence-Based Chemotherapy for Oral Cancer: Focus on Drug Resistance Related to the Epithelial-Mesenchymal Transition. Biomolecules 2021; 11(6): 893 doi: 10.3390/biom11060893
|
| 9 |
Jaleh Varshosaz, Sara Riahi, Erfaneh Ghassami, Ali Jahanian-Najafabadi. Transferrin-targeted poly(butylene adipate)/terephthalate nanoparticles for targeted delivery of 5-fluorouracil in HT29 colorectal cancer cell line. Journal of Bioactive and Compatible Polymers 2017; 32(5): 503 doi: 10.1177/0883911517690756
|
| 10 |
Diego Novick, Felice Leonardi, Daniel Lee Kay Pen, M. E. Montoya-Restrepo, Cristina Avendaño, Sara Siddi, Maria V. Moneta, J. M. Haro, Juan Carlos Velasquez. Retrospective analysis of patients with advanced or metastatic gastric cancer in Colombia. Journal of Medical Economics 2019; 22(9): 891 doi: 10.1080/13696998.2019.1617161
|
| 11 |
Sona Vodenkova, Tomas Buchler, Klara Cervena, Veronika Veskrnova, Pavel Vodicka, Veronika Vymetalkova. 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future. Pharmacology & Therapeutics 2020; 206: 107447 doi: 10.1016/j.pharmthera.2019.107447
|
| 12 |
Nedal Bukhari, Hani Al-Mohanna, Fahad Almsned. Thymidylate Synthase (TYMS) and Methylenetetrahydrofolate Reductase (MTHFR) Gene Polymorphisms Associated With Severe Capecitabine Toxicity: The First Case From Saudi Arabia. Cureus 2023; doi: 10.7759/cureus.49215
|
| 13 |
Amit K. Jain, Sanyog Jain. Advances in oral delivery of anti-cancer prodrugs. Expert Opinion on Drug Delivery 2016; 13(12): 1759 doi: 10.1080/17425247.2016.1200554
|
| 14 |
Claire Palles, Susan Fotheringham, Laura Chegwidden, Marie Lucas, Rachel Kerr, Guy Mozolowski, Dan Rosmarin, Jenny C. Taylor, Ian Tomlinson, David Kerr. An Evaluation of the Diagnostic Accuracy of a Panel of Variants in DPYD and a Single Variant in ENOSF1 for Predicting Common Capecitabine Related Toxicities. Cancers 2021; 13(7): 1497 doi: 10.3390/cancers13071497
|
| 15 |
Reetu Mukherji, John L. Marshall. Lessons Learned in Managing Patients with Colorectal Cancer During the COVID-19 Pandemic. Current Treatment Options in Oncology 2021; 22(10) doi: 10.1007/s11864-021-00888-3
|
| 16 |
Yarden Ariav, James H Ch’ng, Heather R. Christofk, Noga Ron-Harel, Ayelet Erez. Targeting nucleotide metabolism as the nexus of viral infections, cancer, and the immune response. Science Advances 2021; 7(21) doi: 10.1126/sciadv.abg6165
|
| 17 |
Cátia Venâncio, Bruna Monteiro, Isabel Lopes, Ana C. A. Sousa. Assessing the risks of capecitabine and its active metabolite 5-fluorouracil to freshwater biota. Environmental Science and Pollution Research 2023; 30(20): 58841 doi: 10.1007/s11356-023-26505-4
|
| 18 |
Ruben Vardanyan, Victor Hruby. Synthesis of Best-Seller Drugs. 2016; : 495 doi: 10.1016/B978-0-12-411492-0.00028-6
|
| 19 |
Dan Zhang, Jiarui Wu, Kaihuan Wang, Xiaojiao Duan, Shi Liu, Bing Zhang. Which are the best Chinese herbal injections combined with XELOX regimen for gastric cancer?. Medicine 2018; 97(12): e0127 doi: 10.1097/MD.0000000000010127
|
| 20 |
Gary Mitchell, Sam Porter, Elizabeth Manias. Enabling sustained communication with patients for safe and effective management of oral chemotherapy: A longitudinal ethnography. Journal of Advanced Nursing 2021; 77(2): 899 doi: 10.1111/jan.14634
|
| 21 |
William H. Gmeiner. Chemistry of Fluorinated Pyrimidines in the Era of Personalized Medicine. Molecules 2020; 25(15): 3438 doi: 10.3390/molecules25153438
|
| 22 |
Michael Chahin, Nithya Krishnan, Hardik Chhatrala, Marwan Shaikh. A 5-Fluorouracil-Induced Hyperammonemic Encephalopathy Challenged with Capecitabine. Case Reports in Oncological Medicine 2020; 2020: 1 doi: 10.1155/2020/4216752
|
| 23 |
Graciela Gigola, Pedro Carriere, María Belén Novoa Díaz, Gabriela Perdigon, Ariel Osvaldo Zwenger, Claudia Gentili. Survival effect of probiotics in a rat model of colorectal cancer treated with capecitabine. World Journal of Gastrointestinal Oncology 2021; 13(10): 1518-1531 doi: 10.4251/wjgo.v13.i10.1518
|
| 24 |
Jia Luo, ZhouXue Wu, Yun Lu, Kang Xiong, Qian Wen, Ling Zhao, BiQiong Wang, Yan Gui, ShaoZhi Fu. Intraperitoneal administration of biocompatible hyaluronic acid hydrogel containing multi-chemotherapeutic agents for treatment of colorectal peritoneal carcinomatosis. International Journal of Biological Macromolecules 2020; 152: 718 doi: 10.1016/j.ijbiomac.2020.02.326
|
| 25 |
M.B. Cristóvão, R. Janssens, A. Yadav, S. Pandey, P. Luis, B. Van der Bruggen, K.K. Dubey, M.K. Mandal, J.G. Crespo, V.J. Pereira. Predicted concentrations of anticancer drugs in the aquatic environment: What should we monitor and where should we treat?. Journal of Hazardous Materials 2020; 392: 122330 doi: 10.1016/j.jhazmat.2020.122330
|